Sfoglia per Autore
Circulating CD4+CD161+CD196+ Th17 cells are not increased in immune thrombocytopenia
2011 D. Sollazzo;S. Trabanelli;A. Curti;N. Vianelli;R. M. Lemoli;L. Catani
The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF.
2011 D'Addio A; Curti A; Worel N; Douglas K; Motta MR; Rizzi S; Dan E; Taioli S; Giudice V; Agis H; Kopetzky G; Soutar R; Casadei B; Baccarani M; Lemoli R.M.
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients.
2011 Curti A.; Ruggeri L.; D'Addio A.; Bontadini A.; Dan E.; Motta M.R.; Trabanelli S.; Giudice V.; Urbani E.; Martinelli G.; Paolini S.; Fruet F.; Isidori A.; Parisi S.; Bandini G.; Baccarani M.; Velardi A.; Lemoli R.M.
The CD47 pathway is deregulated in human immune thrombocytopenia
2011 Catani L.; Sollazzo D.; Ricci F.; Polverelli N.; Palandri F.; Baccarani M.; Vianelli N.; Lemoli R.M.
Purinergic stimulation of human mesenchymal stem cells potentiates their chemotactic response to CXCL12 and increases the homing capacity and production of proinflammatory cytokines.
2011 Ferrari D; Gulinelli S; Salvestrini V; Lucchetti G; Zini R; Manfredini R; Caione L; Piacibello W; Ciciarello M; Rossi L; Idzko M; Ferrari S; Di Virgilio F; Lemoli R.M.
Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA.
2012 Douglas KW; Parker AN; Hayden PJ; Rahemtulla A; D'Addio A; Lemoli R.M.; Rao K; Maris M; Pagliuca A; Uberti J; Scheid C; Noppeney R; Cook G; Bokhari SW; Worel N; Mikala G; Masszi T; Taylor R; J Treisman.
Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomide.
2012 Malard F.; Kröger N.; Gabriel I.H.; Hübel K.; Apperley J.F.; Basak G.W.; Douglas K.W.; Geraldes C.; Jaksic O.; Koristek Z.; Lanza F.; Lemoli R.M.; Mikala G.; Selleslag D.; Worel N.; Mohty M.; Duarte R.F.
Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo italianoTrapianto di Midollo Osseo.
2012 Olivieri A.; Marchetti M.; Lemoli R.M; Tarella C.; Iacone A.; Lanza F.; Rambaldi A.; Bosi A.
Indoleamine 2,3-Dioxygenase (IDO) Is Associated with High Incidence of Chemorefractory Disease in Acute Myeloid Leukemia (AML) Patients
2012 Sarah Parisi; Sara Trabanelli; Darina Ocadlikova; Stefania Paolini; Cristina Papayannidis; Emanuela Ottaviani; Giovanni Martinelli; Michele Baccarani; Roberto Massimo Lemoli; Antonio Curti
CD 133+ stem cells for the treatment of end stage liver disease.
2012 L. Brodosi; L. Catani; S. Lorenzini; R. Giordano; S. Rizzi; V. Giudice; D. Sollazzo; B. Nicolini; E. Montelatici; T. Montemurro; E. Dan; E. Massari; M. Baccarani; M. Bernardi; R. M. Lemoli; P. Andreone.
Extracellular ATP exerts opposite effects on activated and regulatory CD4 + T cells via purinergic P2 receptor activation
2012 Trabanelli S; Ocadlíková D;Gulinelli S;Curti A;Salvestrini V; de Paula Vieira R;Idzko M;Di Virgilio F; Ferrari D;Lemoli R.M.
European data on stem cell mobilization with plerixafor in patients with nonhematologic diseases: an analysis of the European consortium of stem cell mobilization.
2012 Worel N; Apperley JF; Basak GW; Douglas KW; Gabriel IH; Geraldes C; Hübel K; Jaksic O; Koristek Z; Lanza F; Lemoli R; Mikala G; Selleslag D; Duarte RF; Mohty M.
Pre-emptive use of Plerixafor in hard-to-mobilize patients: An emerging concept.
2012 Jantunen E; Lemoli R.M.
European Data on Stem Cell Mobilization with Plerixafor in Non-Hodgkin’s Lymphoma, Hodgkin’s Lymphoma and Multiple Myeloma Patients. A Subgroup Analysis of the European Consortium of Stem Cell Mobilization.
2012 Hübel K; Fresen MM; Apperley JF; Basak GW; Douglas KW; Gabriel IH; Geraldes C; Jaksic O; Koristek Z; Kröger N; Lanza F; Lemoli RM; Mikala G; Selleslag D; Worel N; Mohty M; Duarte RF.
New strategies for stem cell mobilization
2012 Lemoli R.M.
Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF.
2012 Basak G.W.; Wiktor Jedrzejczak W.; Apperley J.F.; Douglas K.W.; Gabriel I.H.; Geraldes C.; Hübel K.; Jaksic O.; Koristek Z.; Lanza F.; Lemoli R.; Mikala G.; Selleslag D.; Worel N.; Mohty M.; Duarte R.F.
Purinergic signaling inhibits human acute myeloblastic leukemia cell proliferation, migration, and engraftment in immunodeficient mice.
2012 Salvestrini V.; Zini R.; Rossi L.; Gulinelli S.; Manfredini R.; Bianchi E.; Piacibello W.; Caione L.; Migliardi G.; Ricciardi M.R.; Tafuri A.; Romano M.; Salati S.; Di Virgilio F.; Ferrari S.; Baccarani M.; Ferrari D.; Lemoli R.M.
The sixth sense: Hematopoietic Stem Cells detect danger through purinergic signalling.
2012 Rossi L; Salvestrini V; Ferrari D; Di Virgilio F; Lemoli R.M.
Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages.
2013 Ciciarello M; Zini R; Rossi L; Salvestrini V; Ferrari D; Manfredini R; Lemoli RM.
Gpr171, a putative P2Y-like receptor, negatively regulates myeloid differentiation in murine hematopoietic progenitors.
2013 Rossi L.; Lemoli R.M.; Goodell M.A.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Circulating CD4+CD161+CD196+ Th17 cells are not increased in immune thrombocytopenia | D. Sollazzo;S. Trabanelli;A. Curti;N. Vianelli;R. M. Lemoli;L. Catani | 2011-01-01 | HAEMATOLOGICA | - | 1.04 Replica / breve intervento (e simili) | - |
| The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF. | D'Addio A; Curti A; Worel N; Douglas K; Motta MR; Rizzi S; Dan E; Taioli S; Giudice V; Agis H; Ko...petzky G; Soutar R; Casadei B; Baccarani M; Lemoli R.M. | 2011-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients. | Curti A.; Ruggeri L.; D'Addio A.; Bontadini A.; Dan E.; Motta M.R.; Trabanelli S.; Giudice V.; Ur...bani E.; Martinelli G.; Paolini S.; Fruet F.; Isidori A.; Parisi S.; Bandini G.; Baccarani M.; Velardi A.; Lemoli R.M. | 2011-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| The CD47 pathway is deregulated in human immune thrombocytopenia |
Catani L.; Sollazzo D.; Ricci F.; Polverelli N.; Palandri F.; Baccarani M.; Vianelli N.; Lemoli ...R.M. |
2011-01-01 | EXPERIMENTAL HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Purinergic stimulation of human mesenchymal stem cells potentiates their chemotactic response to CXCL12 and increases the homing capacity and production of proinflammatory cytokines. |
Ferrari D; Gulinelli S; Salvestrini V; Lucchetti G; Zini R; Manfredini R; Caione L; Piacibello W...; Ciciarello M; Rossi L; Idzko M; Ferrari S; Di Virgilio F; Lemoli R.M. |
2011-01-01 | EXPERIMENTAL HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA. | Douglas KW; Parker AN; Hayden PJ; Rahemtulla A; D'Addio A; Lemoli R.M.; Rao K; Maris M; Pagliuca ...A; Uberti J; Scheid C; Noppeney R; Cook G; Bokhari SW; Worel N; Mikala G; Masszi T; Taylor R; J Treisman. | 2012-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomide. | Malard F.; Kröger N.; Gabriel I.H.; Hübel K.; Apperley J.F.; Basak G.W.; Douglas K.W.; Geraldes C....; Jaksic O.; Koristek Z.; Lanza F.; Lemoli R.M.; Mikala G.; Selleslag D.; Worel N.; Mohty M.; Duarte R.F. | 2012-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo italianoTrapianto di Midollo Osseo. | Olivieri A.; Marchetti M.; Lemoli R.M; Tarella C.; Iacone A.; Lanza F.; Rambaldi A.; Bosi A. | 2012-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Indoleamine 2,3-Dioxygenase (IDO) Is Associated with High Incidence of Chemorefractory Disease in Acute Myeloid Leukemia (AML) Patients | Sarah Parisi; Sara Trabanelli; Darina Ocadlikova; Stefania Paolini; Cristina Papayannidis; Emanue...la Ottaviani; Giovanni Martinelli; Michele Baccarani; Roberto Massimo Lemoli; Antonio Curti | 2012-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| CD 133+ stem cells for the treatment of end stage liver disease. | L. Brodosi; L. Catani; S. Lorenzini; R. Giordano; S. Rizzi; V. Giudice; D. Sollazzo; B. Nicolini;... E. Montelatici; T. Montemurro; E. Dan; E. Massari; M. Baccarani; M. Bernardi; R. M. Lemoli; P. Andreone. | 2012-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Extracellular ATP exerts opposite effects on activated and regulatory CD4 + T cells via purinergic P2 receptor activation | Trabanelli S; Ocadlíková D;Gulinelli S;Curti A;Salvestrini V; de Paula Vieira R;Idzko M;Di Virgil...io F; Ferrari D;Lemoli R.M. | 2012-01-01 | JOURNAL OF IMMUNOLOGY | - | 1.01 Articolo in rivista | - |
| European data on stem cell mobilization with plerixafor in patients with nonhematologic diseases: an analysis of the European consortium of stem cell mobilization. | Worel N; Apperley JF; Basak GW; Douglas KW; Gabriel IH; Geraldes C; Hübel K; Jaksic O; Koristek Z...; Lanza F; Lemoli R; Mikala G; Selleslag D; Duarte RF; Mohty M. | 2012-01-01 | TRANSFUSION | - | 1.01 Articolo in rivista | - |
| Pre-emptive use of Plerixafor in hard-to-mobilize patients: An emerging concept. | Jantunen E; Lemoli R.M. | 2012-01-01 | TRANSFUSION | - | 1.01 Articolo in rivista | - |
| European Data on Stem Cell Mobilization with Plerixafor in Non-Hodgkin’s Lymphoma, Hodgkin’s Lymphoma and Multiple Myeloma Patients. A Subgroup Analysis of the European Consortium of Stem Cell Mobilization. | Hübel K; Fresen MM; Apperley JF; Basak GW; Douglas KW; Gabriel IH; Geraldes C; Jaksic O; Koristek... Z; Kröger N; Lanza F; Lemoli RM; Mikala G; Selleslag D; Worel N; Mohty M; Duarte RF. | 2012-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| New strategies for stem cell mobilization | Lemoli R.M. | 2012-01-01 | MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES | - | 1.01 Articolo in rivista | - |
| Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF. | Basak G.W.; Wiktor Jedrzejczak W.; Apperley J.F.; Douglas K.W.; Gabriel I.H.; Geraldes C.; Hübel ...K.; Jaksic O.; Koristek Z.; Lanza F.; Lemoli R.; Mikala G.; Selleslag D.; Worel N.; Mohty M.; Duarte R.F. | 2012-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Purinergic signaling inhibits human acute myeloblastic leukemia cell proliferation, migration, and engraftment in immunodeficient mice. |
Salvestrini V.; Zini R.; Rossi L.; Gulinelli S.; Manfredini R.; Bianchi E.; Piacibello W.; Caione... L.; Migliardi G.; Ricciardi M.R.; Tafuri A.; Romano M.; Salati S.; Di Virgilio F.; Ferrari S.; Baccarani M.; Ferrari D.; Lemoli R.M. |
2012-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| The sixth sense: Hematopoietic Stem Cells detect danger through purinergic signalling. | Rossi L; Salvestrini V; Ferrari D; Di Virgilio F; Lemoli R.M. | 2012-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages. | Ciciarello M; Zini R; Rossi L; Salvestrini V; Ferrari D; Manfredini R; Lemoli RM. | 2013-01-01 | STEM CELLS AND DEVELOPMENT | - | 1.01 Articolo in rivista | - |
| Gpr171, a putative P2Y-like receptor, negatively regulates myeloid differentiation in murine hematopoietic progenitors. | Rossi L.; Lemoli R.M.; Goodell M.A. | 2013-01-01 | EXPERIMENTAL HEMATOLOGY | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile